Last reviewed · How we verify
Antiplatelet Medical Therapy
At a glance
| Generic name | Antiplatelet Medical Therapy |
|---|---|
| Also known as | Aspirin, Dipyridamole, Aggrenox, Clopidogrel, Plavix |
| Sponsor | W.L.Gore & Associates |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Palpitations
- Headache
- Dizziness
- Upper respiratory tract infection
- Non-cardiac chest pain
- Atrial fibrillation
- Hypertension
- Dysaesthesia
- Arthralgia
- Back pain
- Pain in extremity
- Anxiety
Key clinical trials
- Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure (NA)
- Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion (NA)
- Chaigui Longmu Ejiao Paste for Ischemic Heart Disease (PHASE2)
- Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window (PHASE3)
- Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging (PHASE3)
- Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke
- Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone (PHASE3)
- REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antiplatelet Medical Therapy CI brief — competitive landscape report
- Antiplatelet Medical Therapy updates RSS · CI watch RSS
- W.L.Gore & Associates portfolio CI